Bausch & Lomb Corp

BLCO

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
BLCO
CIK0001860742
SIC3851
SectorManufacturing
Industry CategoryMedical Equipment
Industry GroupOphthalmic Goods

Contact

Address520 APPLEWOOD CRESCENT, VAUGHAN, A6, L4K 4B4
Website bausch.com
Phone908-541-5456
CEOJoseph C. Papa
Employees12,500

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$4.83 billion
Pre-Tax Income$-324.00 million
Net Income$-353.00 million
Net Income to Common$-362.00 million
EPS$-1.02
View All
Balance Sheet
Cash$202.00 million
Assets$13.43 billion
Liabilities$7.00 billion
Common Equity$6.36 billion
Liabilities & Equity$13.43 billion
View All
Cash Flow Statement
Net Income$-353.00 million
Cash From Operating Activities$166.00 million
Cash From Investing Activities$-471.00 million
Cash From Financing Activities$197.00 million
Change in Cash$-110.00 million
View All
Calculations
NOPAT$51.10 million
EBITDA$591.00 million
Price to EarningsN/A
Price to Book$0.65
ROE-5.36%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering

Bausch + Lomb Corporation (BLCO.TO), a global eye health company, on Wednesday said its Bausch+Lomb

Article Link

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

VAUGHAN, Ontario, June 18, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the "Issuers"), have priced the offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031 ("Notes"). The size of the offering was increased fr

Article Link

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement

VAUGHAN, Ontario, June 10, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the "Issuers"), have launched an offering of €600 million aggregate principal amount of senior secured floating rate notes ("Notes").

Article Link

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

VAUGHAN, Ontario, June 04, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops. Both products are preservative-free, contact-lens friendly and uniquely formulated to provide hydration and comfort for dry eyes in a multi-dose bottle.

Article Link

1 Safe-and-Steady Stock for Long-Term Investors and 2 to Question

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Article Link